Pictet Asset Management Holding SA »

Supernus Pharmaceuticals shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-09-30 $17M 561k 30.76
2024-03-31 $34M 990k 33.93

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Republic Services (RSG)
Meta Platforms Cl A (META)
salesforce (CRM)
Waste Connections (WCN)
Equinix (EQIX)
Ecolab (ECL)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Broadcom (AVGO)

View all positions for Pictet Asset Management Holding SA

Top funds holding Supernus Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
Armistice Capital
Dimensional Fund Advisors
Macquarie Group
State Street Corporation
Stephens Investment Management Group
Pacer Advisors
Renaissance Technologies
Geode Capital Management
Jennifer Ranahan
Aristotle Capital Boston
American Century Companies
Victory Capital Management

View all funds holding Supernus Pharmaceuticals